Knockdown of mouse VCAM-1 by vector-based siRNA

Transplant Immunology

Volumn 16, Issue 3-4, 2006, Pages 185-193

  Alam, A K M Shamsul ^a   Florey, Oliver ^b   Weber, Michele ^a   Pillai, Radhakrishna G ^a   Chan, Cliburn ^a   Tan, Peng H ^a   Lechler, Robert I ^a   McClure, Myra O ^c   Haskard, Dorian O ^b   George, Andrew J T ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c Wright Fleming Institute   (United Kingdom)

Author keywords

Adhesion molecules; ER stress; Inflammation; Interferon response; Leukocyte adhesion; siRNA; Transplantation; VCAM 1; Vector based siRNA

Indexed keywords

CELL ADHESION MOLECULE; CYTOKINE; PROGRAMMED DEATH LIGAND 1; PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ARTICLE; CELL GROWTH; CONTROLLED STUDY; CORNEA ENDOTHELIUM; EMBRYO; ENDOTHELIUM CELL; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STRESS; T LYMPHOCYTE; VASCULAR ENDOTHELIUM;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; BLOTTING, WESTERN; CELL ADHESION; CELL LINE; CELL PROLIFERATION; CLONING, MOLECULAR; CORNEA; DNA PRIMERS; ENDOTHELIAL CELLS; FLOW CYTOMETRY; GENETIC TECHNIQUES; GENETIC VECTORS; HUMANS; MICE; OXIDATIVE STRESS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; TRANSFECTION; VASCULAR CELL ADHESION MOLECULE-1;

EID: 33751435464     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2006.08.004     Document Type: Article

References (44)

1. Springer T.A. Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu Rev Physiol 57 (1995) 827-872
2. Jones D.A., McIntire L.V., Smith C.W., and Picker L.J. A two-step adhesion cascade for T cell/endothelial cell interactions under flow conditions. J Clin Invest 94 (1994) 2443-2450
3. Briscoe D.M., Schoen F.J., Rice G.E., Bevilacqua M.P., Ganz P., and Pober J.S. Induced expression of endothelial-leukocyte adhesion molecules in human cardiac allografts. Transplantation 51 (1991) 537-539
4. Osborn L., Hession C., Tizard R., Vassallo C., Luhowskyj S., Chi-Rosso G., et al. Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell 59 (1989) 1203-1211
5. Mebius R.E. Organogenesis of lymphoid tissues. Nat Rev Immunol 3 4 (2003) 292-303
6. Stegall M.D., Ostrowska A., Haynes J., Karrer F., Kam I., and Gill R.G. Prolongation of islet allograft survival with an antibody to vascular cell adhesion molecule 1. Surgery 118 2 (Aug 1995) 366-369 [discussion 9-70]
7. Berlin P.J., Bacher J.D., Sharrow S.O., Gonzalez C., and Gress R.E. Monoclonal antibodies against human T cell adhesion molecules-modulation of immune function in nonhuman primates. Transplantation 53 4 (Apr 1992) 840-849
8. Orosz C.G., Ohye R.G., Pelletier R.P., Van Buskirk A.M., Huang E., Morgan C., et al. Treatment with anti-vascular cell adhesion molecule 1 monoclonal antibody induces long-term murine cardiac allograft acceptance. Transplantation 56 2 (Aug 1993) 453-460
9. Stegall M.D., Dean P.G., Ninova D., Cohen A.J., Shepard G.M., Gup C., et al. Alpha4 integrin in islet allograft rejection. Transplantation 71 11 (Jun 15 2001) 1549-1555
10. Gorczynski R.M., Fu X.M., Issekutz T., and Cohen Z. Differential regulation of rejection of small intestinal and skin allografts in rats by injection of antibodies to ICAM-1 or the integrins alpha 4, alpha L, or beta 2. Cell Immunol 184 1 (Feb 25 1998) 74-82
11. Hannon G.J. RNA interference. Nature 418 (2002) 244-251
12. Lilley D.M. The ribosome functions as a ribozyme. Chembiochem 2 1 (Jan 8 2001) 31-35
13. Sedivy J.M., and Sharp P.A. Positive genetic selection for gene disruption in mammalian cells by homologous recombination. Proc Natl Acad Sci U S A 86 1 (Jan 1989) 227-231
14. Rondon I.J., and Marasco W.A. Intracellular antibodies (intrabodies) for gene therapy of infectious diseases. Annu Rev Microbiol 51 (1997) 257-283
15. Gurtner G.C., Davis V., Li H., McCoy M.J., Sharpe A., and Cybulsky M.I. Targeted disruption of the murine VCAM1 gene: Essential role of VCAM-1 in chorioallantoic fusion and placentation. Genes Dev 9 1 (Jan 1 1995) 1-14
16. Sharp P.A. RNAi and double-strand RNA. Genes Dev 13 2 (Jan 15 1999) 139-141
17. Hunter T., Hunt T., Jackson R.J., and Robertson H.D. The characteristics of inhibition of protein synthesis by double-stranded ribonucleic acid in reticulocyte lysates. J Biol Chem 250 2 (Jan 25 1975) 409-417
18. Elbashir S.M., Lendeckel W., and Tuschl T. RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev 15 2 (Jan 15 2001) 188-200
19. Brummelkamp T.R., Bernards R., and Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 296 5567 (Apr 19 2002) 550-553
20. Graham F.L., Smiley J., Russell W.C., and Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36 1 (Jul 1977) 59-74
21. Wilson S.E., Weng J., Blair S., He Y.G., and Lloyd S. Expression of E6/E7 or SV40 large T antigen-coding oncogenes in human corneal endothelial cells indicates regulated high-proliferative capacity. Invest Ophthalmol Vis Sci 36 1 (Jan 1995) 32-40
22. Williams R.L., Courtneidge S.A., and Wagner E.F. Embryonic lethalities and endothelial tumors in chimeric mice expressing polyoma virus middle T oncogene. Cell 52 1 (Jan 15 1988) 121-131
23. Weiss A., and Stobo J.D. Requirement for the coexpression of T3 and the T cell antigen receptor on a malignant human T cell line. J Exp Med 160 5 (Nov 1 1984) 1284-1299
24. Tan P.H., Chan C., Xue S.A., Dong R., Ananthesayanan B., Manunta M., et al. Phenotypic and functional differences between human saphenous vein (HSVEC) and umbilical vein (HUVEC) endothelial cells. Atherosclerosis 173 2 (Apr 2004) 171-183
25. Rao R.M., Clarke J.L., Ortlepp S., Robinson M.K., Landis R.C., and Haskard D.O. The S128R polymorphism of E-selectin mediates neuraminidase-resistant tethering of myeloid cells under shear flow. Eur J Immunol 32 1 (Jan 2002) 251-260
26. Martinez M.A., Clotet B., and Este J.A. RNA interference of HIV replication. Trends Immunol 23 12 (Dec 2002) 559-561
27. McManus M.T., Haines B.B., Dillon C.P., Whitehurst C.E., van Parijs L., Chen J., et al. Small interfering RNA-mediated gene silencing in T lymphocytes. J Immunol 169 10 (Nov 15 2002) 5754-5760
28. Shlomai A., and Shaul Y. Inhibition of hepatitis B virus expression and replication by RNA interference. Hepatology 37 4 (Apr 2003) 764-770
29. Sui G., Soohoo C., Affarel B., Gay F., Shi Y., Forrester W.C., et al. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc Natl Acad Sci U S A 99 8 (Apr 16 2002) 5515-5520
30. Fire A., Xu S., Montgomery M.K., Kostas S.A., Driver S.E., and Mello C.C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391 6669 (Feb 19 1998) 806-811
31. Hamilton A.J., and Baulcombe D.C. A species of small antisense RNA in posttranscriptional gene silencing in plants. Science 286 5441 (Oct 29 1999) 950-952
32. Moore M.D., McGarvey M.J., Russell R.A., Cullen B.R., and McClure M.O. Stable inhibition of hepatitis B virus proteins by small interfering RNA expressed from viral vectors. J Gene Med 7 7 (Jul 2005) 918-925
33. Lee M.T., Coburn G.A., McClure M.O., and Cullen B.R. Inhibition of human immunodeficiency virus type 1 replication in primary macrophages by using Tat- or CCR5-specific small interfering RNAs expressed from a lentivirus vector. J Virol 77 22 (Nov 2003) 11964-11972
34. Li W.L., Cheng X., Tan X.H., Zhang J.S., Sun Y.S., Chen L., et al. Endothelial cell-specific expression of Cre recombinase in transgenic mice. Yi Chuan Xue Bao 32 9 (Sep 2005) 909-915
35. Bridge A.J., Pebernard S., Ducraux A., Nicoulaz A.L., and Iggo R. Induction of an interferon response by RNAi vectors in mammalian cells. Nat Genet 34 3 (Jul 2003) 263-264
36. Hiasa Y., Kamegaya Y., Nuriya H., Onji M., Kohara M., Schmidt E.V., et al. Protein kinase R is increased and is functional in hepatitis C virus-related hepatocellular carcinoma. Am J Gastroenterol 98 11 (Nov 2003) 2528-2534
37. Thomis D.C., and Samuel C.E. Mechanism of interferon action: Characterization of the intermolecular autophosphorylation of PKR, the interferon-inducible, RNA-dependent protein kinase. J Virol 69 8 (Aug 1995) 5195-5198
38. Sledz C.A., Holko M., de Veer M.J., Silverman R.H., and Williams B.R. Activation of the interferon system by short-interfering RNAs. Nat Cell Biol 5 9 (Sep 2003) 834-839
39. Sledz C.A., and Williams B.R. RNA interference and double-stranded-RNA-activated pathways. Biochem Soc Trans 32 Pt 6 (Dec 2004) 952-956
40. Lee J.H., Park E.J., Kim O.S., Kim H.Y., Joe E.H., and Jou I. Double-stranded RNA-activated protein kinase is required for the LPS-induced activation of STAT1 inflammatory signaling in rat brain glial cells. Glia 50 1 (Apr 1 2005) 66-79
41. Domitrovich A.M., and Kunkel G.R. Multiple, dispersed human U6 small nuclear RNA genes with varied transcriptional efficiencies. Nucleic Acids Res 31 9 (May 1 2003) 2344-2352
42. Pebernard S., and Iggo R.D. Determinants of interferon-stimulated gene induction by RNAi vectors. Differentiation 72 2-3 (Mar 2004) 103-111
43. Zhang K., and Kaufman R.J. The unfolded protein response: a stress signaling pathway critical for health and disease. Neurology 66 2 Suppl 1 (Jan 24 2006) S102-S109
44. He B. Viruses, endoplasmic reticulum stress, and interferon responses. Cell Death Differ 13 3 (Mar 2006) 393-403